ScienceThe Next Webabout 2 hours ago
INmune Bio Partners With QCi on Quantum AI
4 min read
On October 14th, 2026, INmune Bio and Quantum Computing Inc. announced a collaboration to apply quantum optimization and AI to advance Alzheimer's drug research. This partnership marks QCi's first commercial customer in the pharmaceutical and biotechnology markets, utilizing the Dirac-3S machine to identify new treatment indications for XPro alongside conventional data analytics.
Level
Hype check
Tap to vote and see what everyone thinks.
